Doctor profile · Federal record
Dr. Maha Assi, MD
Infectious Disease Physician (CMS: Infectious Disease) · Wichita, KS
- NPI 1922071224
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 27 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
310 S Hillside St
Wichita, KS 672112129
(316) 264-3505
fax (316) 264-0908
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- March 17, 2026
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Kansas #04-29896
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1922071224. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
50,300
Distinct HCPCS
10
Medicare allowed
$585,076
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0878 |
Injection, daptomycin, 1 mg | 42,700 | 25 | $0 | |
J1556 |
Injection, immune globulin (bivigam), 500 mg | 3,590 | 37 | $71 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,824 | 360 | $74 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 699 | 193 | $111 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 296 | 266 | $162 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 247 | 114 | $58 | |
J0696 |
Injection, ceftriaxone sodium, per 250 mg | 244 | 20 | $1 | |
J1335 |
Injection, ertapenem sodium, 500 mg | 162 | 34 | $14 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 125 | 93 | $117 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 85 | 46 | $19 |
In context: peer comparison
Among 4 peers in this city , average services per provider: 3,221. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$542
Transactions
20
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Recor Medical Inc | 1 | $110.27 | |
| Amgen Inc. | 1 | $108.38 | |
| Insmed, Inc. | 6 | $99.17 | |
| HOSPIRA, INC. | 4 | $74.29 | |
| Gilead Sciences, Inc. | 3 | $62.91 | |
| ADMA BioManufacturing LLC | 1 | $18.66 | |
| Merck Sharp & Dohme LLC | 1 | $18.53 | |
| ABBVIE INC. | 1 | $17.13 | |
| Octapharma USA, Inc. | 1 | $16.66 | |
| Melinta Therapeutics, LLC | 1 | $15.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
422
Patients
61
Total drug cost
$67,018
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methenamine Hippurate | Generic | 56 | 15 | $3,450 |
| Cephalexin | Generic | 42 | 18 | $738 |
| Cefepime Hcl | Generic | 38 | 14 | $6,339 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 34 | 0 | $1,039 |
| Daptomycin | Generic | 33 | 0 | $24,766 |
| Ertapenem (Ertapenem Sodium) | Brand | 31 | 0 | $16,476 |
| Meropenem | Generic | 26 | 0 | $6,195 |
| Vancomycin Hcl | Generic | 26 | 14 | $3,967 |
| Minocycline Hcl | Generic | 25 | 0 | $1,025 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 23 | 0 | $159 |
Hospital affiliations
Frequently asked questions
What is Dr. Maha Assi's medical specialty?
Dr. Maha Assi practices Infectious Disease Physician in Wichita, KS.
Where does Dr. Maha Assi practice?
Dr. Maha Assi practices at 310 S Hillside St, Wichita, KS 672112129. Office phone: 3162643505.
What is Dr. Maha Assi's NPI?
Dr. Maha Assi's National Provider Identifier (NPI) is 1922071224, issued by NPPES.
Does Dr. Maha Assi accept Medicare assignment?
Yes. Dr. Maha Assi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Maha Assi commonly perform?
Top Medicare-reported procedures in 2023: Injection, daptomycin, 1 mg (HCPCS J0878); Injection, immune globulin (bivigam), 500 mg (HCPCS J1556); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232). Source: CMS Medicare Physician & Other Practitioners file.